Aprea Therapeutics, Inc. Common stock (APRE)

Health Care·equity

$0.60

+8.28% today

Extended hours $0.62

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

26/ 100

Score level

Below average

5 of 6 checks had data

Business numbers score is below the middle; score for how it compares with the broader market is near the bottom of its range; and price trend score is below the middle.

APRE scores higher than 23% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Aprea Therapeutics, Inc. Common stock (APRE) scores 26 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.28× 30-day average
52-week range: 0.55 – 1.69
Market cap: $9.57M
Earnings date: 10 Nov 2026

Volume: 70,586
Avg. volume (30d): 253,902

Open: 0.56
Previous close: 0.56
Day's range (regular session): 0.56 – 0.61

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: -1.24
P/E (TTM): —
EPS (TTM): -1.54

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

—

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about APRE right now

Aprea Therapeutics, Inc. Common stock (APRE) currently scores 26/100 on the Market Census six-factor composite, at the Below average score level. APRE is +8.28% on the day and -13.04% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of APRE's data reads poorly than well. The level is a "look before you act" flag. It is not advice. APRE's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about APRE itself. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See APRE in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score